Found 27 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age PHASE3 A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Show More Location
MHAT St. Ekaterina
Learn More & Join Trial
Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults PHASE2 This study evaluates the safety and immunogenicity of the BPZE1 live attenu...
Show More Location
Rapid medical Research Inc
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) PHASE3 This is a study to assess the safety, tolerability, and immunogenicity of V...
Show More Location
Multiple Locations
Learn More & Join Trial
2-year Follow-up After a Single Dose Acellular Pertussis Vaccination N/A In July 2015-November 2016, a phase II/III randomized, observer-blind,contr...
Show More Location
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi,
Learn More & Join Trial
Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children PHASE2 This study evaluates the safety and immunogenicity of the BPZE1 live, atten...
Show More Location
Sydney Children's Hospital
Learn More & Join Trial
Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults PHASE1 A bivalent Typhoid and Paratyphoid A conjugate investigational vaccine aime...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants PHASE1 The aim of the current clinical study was to evaluate, for the first time i...
Show More Location
GSK Investigational Site
Learn More & Join Trial
5-year Follow-up After a Single Dose Acellular Pertussis Vaccination N/A In July 2015-November 2016, a phase II/III randomized, observer-blind,contr...
Show More Location
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi,
Learn More & Join Trial
A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005) PHASE3 This study will evaluate the tolerability and immunogenicity of administrat...
Show More Location
Multiple Locations
Learn More & Join Trial